CellWell record HH-14506
Safety of very low LDL-cholesterol: Ten common concerns, misconceptions, and evidence-based clarifications.
Zárate-Correa LC; García-Peña Á; Kaiser SE; Aguilar-Salinas CA; Mendez-Castillo M; Mehta R; Valerio CM; Moreira RO; Mancillas-Adame LG; Cetina Canto JA; Parcero JJ; Reyes X; Kayikcioglu M; Tselepis AD; Schreier L; Corral P
Atherosclerosis · 2026
In plain language
A review of randomized trials found intensive LDL cholesterol lowering, including to very low levels, was not associated with increased risk of cognitive impairment, cancer, cataracts, or hemorrhage, though statin therapy carries modest dysglycemia risk.
- Studied in
- Human
Cite this record: https://thecellwell.org/studies/HH-14506
Produced by the CellWell Research Engine, custom software owned and operated by CellWell and The Holistic Hub. All rights reserved. This analysis, its indexing and its evidence classifications are proprietary. Any use, republication or onward sharing must credit CellWell Research Engine (thecellwell.org) as the source.
This is an educational research library, not medical advice. Nothing here may be used to diagnose, treat, cure, or prevent any disease. Always consult a qualified professional.